The results indicate that the GPR30 receptor is involved in cell proliferation induced by IL-6 and E2 in breast cancer and IL-6-induced metastatic properties, such as migration and invasion in luminal, TMX-resistant, and triple-negative cancer cells. This evidence concerns the gene IL6 and breast cancer.